Our results demonstrate that the absence of CCR9 significantly increases the CD8+/Treg ratio in the tumor and peritumoral space, indicating that CCR9 plays a fundamental role in modulating the anti-tumoral immune response in CRC (Fig 5A). The gene discussed is CD8A; the disease is colorectal carcinoma.